Skip to main content

Protalix Biotherapeutics (NY: PLX )

1.280 +0.030 (+2.40%)
Official Closing Price Updated: 4:10 PM EST, Nov 4, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
September 29, 2005
Form 8-K/A
Source: SEC/Edgar
May 17, 2005
Form 8-K
Source: SEC/Edgar
May 12, 2005
Form 8-K/A
Source: SEC/Edgar
November 23, 2004
Form 8-K
Source: SEC/Edgar
November 17, 2004
Form SC 13G/A
Source: SEC/Edgar
September 06, 2004
Form SC 13D/A
Source: SEC/Edgar
August 16, 2004
Form 10QSB
Source: SEC/Edgar
August 12, 2004
Form 25
Source: SEC/Edgar
August 02, 2004
Form SC 13E3/A
Source: SEC/Edgar
July 22, 2004
Form 15-12G
Source: SEC/Edgar
July 22, 2004
Form 8-K
Source: SEC/Edgar
July 22, 2004
Form SC 13D/A
Source: SEC/Edgar
July 20, 2004
Form SC 13G
Source: SEC/Edgar
July 19, 2004
Form 8-K
Source: SEC/Edgar
July 19, 2004
Form SC 13D/A
Source: SEC/Edgar
July 19, 2004
Form SC 13D/A
Source: SEC/Edgar
July 18, 2004
Form SC 13D/A
Source: SEC/Edgar
July 14, 2004
Form SC 13D/A
Source: SEC/Edgar
July 12, 2004
Form DEFA14A
Source: SEC/Edgar
July 12, 2004
Form SC 13E3/A
Source: SEC/Edgar
July 12, 2004
Form SC 13D/A
Source: SEC/Edgar
July 12, 2004
Form 8-K
Source: SEC/Edgar
July 11, 2004
Form SC 13D/A
Source: SEC/Edgar
July 06, 2004
Form 8-K
Source: SEC/Edgar
June 30, 2004
Form DEFM14A
Source: SEC/Edgar
June 22, 2004
Form SC 13E3/A
Source: SEC/Edgar
June 22, 2004
Form SC 13E3/A
Source: SEC/Edgar
June 06, 2004
Form PRER14A
Source: SEC/Edgar
June 06, 2004
Form DEFA14A
Source: SEC/Edgar
May 26, 2004
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.